News
PILL
8.25
+1.35%
0.11
Weekly Report: what happened at PILL last week (0318-0322)?
Weekly Report · 3d ago
Direxion Daily Pharmaceutical & Medical Bull 3X Shares declares quarterly distribution of $0.0272
Seeking Alpha · 03/21 17:37
Weekly Report: what happened at PILL last week (0311-0315)?
Weekly Report · 03/18 10:25
Weekly Report: what happened at PILL last week (0304-0308)?
Weekly Report · 03/11 10:23
Why Biotech Stocks May Be Ready For A Recovery
Biotech stocks have struggled in recent quarters as high interest rates take a toll on the capital-intensive sector. Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with MoneyTalk's Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a recovery.
Seeking Alpha · 03/09 08:59
Weekly Report: what happened at PILL last week (0226-0301)?
Weekly Report · 03/04 10:25
Are Healthcare Stocks A Risky Prescription In A U.S. Election Year?
Seeking Alpha · 02/27 18:15
Weekly Report: what happened at PILL last week (0219-0223)?
Weekly Report · 02/26 10:33
Top Performing Leveraged/Inverse ETFs: 02/18/2024
NASDAQ · 02/21 17:58
The Zacks Analyst Blog Highlights AdvisorShares MSOS 2x Daily ETF, ProShares Ultra Semiconductors, BMO REX MicroSectors FANG+ Index 3X Leveraged ETN, Direxion Daily Pharmaceutical & Medical Bull 3X Shares and Direxion Daily Semiconductor Bull 3x Shar
NASDAQ · 02/21 10:11
5 Best Leveraged ETFs of First Half of Q1
NASDAQ · 02/20 17:05
Weekly Report: what happened at PILL last week (0212-0216)?
Weekly Report · 02/19 10:34
Weekly Report: what happened at PILL last week (0205-0209)?
Weekly Report · 02/12 10:27
Weekly Report: what happened at PILL last week (0129-0202)?
Weekly Report · 02/05 10:32
Weekly Report: what happened at PILL last week (0122-0126)?
Weekly Report · 01/29 10:26
Weekly Report: what happened at PILL last week (0115-0119)?
Weekly Report · 01/22 10:28
Weekly Report: what happened at PILL last week (0108-0112)?
Weekly Report · 01/15 10:26
Week In Review: China Biopharmas Book $9B In Deals During JP Morgan Conference Week
Shanghai Argo Biopharma entered two agreements with Novartis for a total value of $4.2 billion. San Diego’s Ambrx Biopharmas will be acquired by Johnson & Johnson for $2billion. GSK plans to acquire Aiolos Bio for $1 billion upfront and up to $400 million.
Seeking Alpha · 01/14 08:40
Horiba: Wonderful Japanese Company At A Very Attractive Price
Horiba is a Japanese company that has a growing "Life Sciences Tools and Services" segment. The company has high market share in specialized devices in various industries. Horiba has outperformed the S&P 500 index by a significant margin over the past ten years. The Japanese company is likely undervalued and offers a rare combination of a quality business at an attractive price.
Seeking Alpha · 01/12 16:27
Healthcare Outlook 2024
Healthcare sector was flat in 2023 year as a result of unique issues. Drug price regulation will be a serious challenge for the sector this year. We expect the broader S&P Healthcare Index to rise 10% in 2024. The healthcare sector is expected to gain 5%-10% in the first half of 2024.
Seeking Alpha · 01/08 13:31
More
Webull provides a variety of real-time PILL stock news. You can receive the latest news about Direxion Daily Phrmctcl&MdclBl3XShrsETF through multiple platforms. This information may help you make smarter investment decisions.